This systematic review synthesizes published articles investigating the prevalence, severity and impact of urinary incontinence (UI), a condition associated with cystic fibrosis (CF). References were identified through searching Medline, Embase and PubMed using the medical subject headings 'cystic fibrosis' AND 'urinary incontinence'. Articles were included if UI prevalence was investigated as an outcome. Twelve studies met selection criteria. The prevalence of UI ranged from 5% to 76%. Age and gender contributed to this variability. When assessed, UI commonly limited airway clearance, exercise and/or spirometry, and had a variable impact on patients' lives. Worry and embarrassment were features for many; others were less affected. In CF, UI is common and can interfere with respiratory care and social well-being. The prevalence, characteristics and impact are poorly understood, which is made worse by inconsistent definitions across studies. Future research is needed to improve approaches to prevention, identification, management and education.
INTRODUCTION
Advances in therapy and management have led to dramatic increases in the life expectancy of patients with cystic fibrosis (CF). 1 If mortality continues to fall at the rate observed in the past decade, the projected median survival for infants born with CF today is to the sixth decade of life. 2 The significance of extrapulmonary conditions, such as urinary incontinence (UI), increases as survival improves. [3] [4] [5] Nearly 20 years ago, UI was first recognized as a complication of chronic lung disease. 6 Wide variation in the prevalence and severity of UI has been reported in both adults and adolescents with CF, and there has been little focus on the impact of UI on respiratory health or quality of life. 7 While there are various management options for UI, the extent to which these are offered to and accepted by patients is unknown, and their benefits to patients with CF are unclear. Low rates of discussion of UI with healthcare providers have been reported, which would limit patients' access to treatment. 8 Adolescents and adults have reported various barriers to discussions of sexual and reproductive health (SRH), but the extent to which these issues function as obstacles to discussion and treatment of UI is unclear. 9 We set out to undertake a systematic review of UI in both females and males with CF with the goal of identifying the prevalence, severity and impact of this condition. In doing so, we wish to highlight the opportunities for research that improves current understanding, future management and approaches to prevention.
METHODS

Search strategy and selection criteria
References were identified through searching Medline, Embase and PubMed databases using the medical subject headings 'cystic fibrosis' AND 'urinary incontinence'. The search was restricted to papers published in English from January 1990 to October 2016. Papers were included if UI prevalence was investigated as an outcome.
As shown in Figure 1 , 64 records were identified after removal of duplicates. These papers, and any relevant references cited within them, were then reviewed in full. Exclusion of case reports, conference abstracts, literature reviews and clinical practice guidelines resulted in 19 research papers, of which 12 were original research studies that explored the prevalence of UI in CF. Two review authors independently extracted data from included reports, including prevalence, severity, triggers/association and impact measures around UI in CF. Potential for bias was assessed by consideration of representativeness of study population, completeness of outcome data and selective outcome reporting.
RESULTS
A summary of the 12 identified research papers about the prevalence, severity and impact of UI in CF is provided in Table 1. 10-21 These studies spanned a variety of countries, and included a wide age range of participants. There were few studies of males. As a group, the studies are noteworthy for the lack of consistent definitions of UI prevalence and severity, such as frequency and volume. No bias was noted regarding identified studies or outcomes.
Prevalence and severity
The prevalence of UI ranged from 5% to 76%. Both age and gender contributed to this variability; UI was more prevalent in adults than adolescents, and in females more than males.
Studies of women and girls
The majority of published research focuses on adult women with CF, in whom the reported prevalence of UI ranges from 30% to 76%. Most studies did not find a clear association with CF disease severity as measured by percent predicted forced expiratory volume in 1 s (FEV 1 ). White et al. found that 38% of 27 adult women experienced UI, with the majority reporting small amounts of urine leakage. The frequency of UI ranged from occasional incontinence to four times a week. There was no correlation with CF disease severity. 10 A report by Orr et al. found that 68% of 75 adult women reported UI; 27% only reported UI during pulmonary exacerbations. 12 Among 46 adult women from Northern Ireland, 30% reported UI, in whom no association was noted with CF disease severity.
14 Of the 14 patients with UI, 29% reported UI at least once per week, but 71% reported urine leakage of only 'a few drops at a time'. In a larger study of 146 women, Vella et al. reported that 74% had experienced UI, of whom 60% rated the severity of UI as 'mild', 22% as 'moderate' and 18% as 'severe'. The association with disease severity was not examined. 18 Three studies that included both adolescent girls and adult women found an association between UI and markers of CF disease severity. A survey of 176 young women aged 15-41 years (mean AE SD age: 24.6 AE 5.8 years) found that 59% had experienced UI. 11 The frequency of UI was defined as regular (twice/month or more for two consecutive months) in 24% of participants with a further 35% reporting occasional UI. Both increasing age and lower FEV 1 were significantly associated with UI frequency. A study of 64 young Polish women with CF (mean AE SD age: 20.9 AE 1.5 years) found that 44% experienced UI. 19 The majority (86%) reported UI more than once per year, with 58% endorsing moderate severity of incontinence (defined as 'wet/a small amount'). No association was noted between UI and FEV 1 , body mass index (BMI), CF-related diabetes (CFRD) or presence of a gastrostomy tube. However, women with UI reported significantly more pulmonary exacerbations compared with their continent counterparts. A recent study by Reichman et al. included both male and female patients with CF aged 6 years and older. 21 Seventy-six percent of the 25 adult women reported UI. Results regarding frequency and volume of urine leakage were presented for patients over 12 years, of whom 24% were reported to leak urine at least yearly, 45% at least monthly and 31% at least weekly. Sixtyseven percent of patients reported that they 'drip urine'. Patients with more hospitalizations for pulmonary exacerbations were at higher risk of reporting UI; no other markers of disease severity were explored.
There are fewer studies of UI in children or adolescents with CF, most of which have studied girls. Nixon et al. were the first to focus on younger patients, in whom 47% of 55 girls aged 12-19 years reported ever having UI. 13 The majority reported UI infrequently (once a year or more), with no association noted with BMI, FEV 1 , forced vital capacity (FVC), CFRD, presence of a gastrostomy tube or number of hospitalizations in the past year. Seventy-nine percent reported smallvolume urine leakage ('damp/a few drops'). A study in the UK found that UI was present in 44% of 26 girls and 2.2% of 46 boys aged 5-18 years. 15 No significant association was noted with severity of CF disease or FEV 1 . The majority of cases of UI were classified as mild in terms of frequency and severity of leakage (less than once a week and no more than 'a few drops' of urine). Reichman et al. found that in a sample of 14 girls aged 6-11 years, none reported UI. 21 Two paediatric studies utilized comparison groups in their analysis. Prasad et al. found that the prevalence of UI in 51 girls with CF was significantly higher (33%) than in girls with asthma (16%) and healthy girls (7%) (P = 0.02). 16 Of the patients with CF, the majority reported small-volume urine leakage ('a few drops only') and no association with pulmonary exacerbations. Browne et al. compared 9-16-year-old male and female Records not meeting eligibility criteria: Literature reviews (n=18) Case reports (n=2) Clinical practice guidelines (n=2) Study population not cystic fibrosis (n=4) Prevalence, impact or severity of urinary incontinence not a primary outcome (n=3) 41 Full-text articles assessed for eligibility 12 Original research studies included in review Figure 1 Literature search flow diagram. Summary of records identified through database search and assessed for eligibility criteria. Table 1 UI in CF. Summary of studies that have explored the prevalence (%), associations with severity of CF and impact of UI, together with the proportion (%) who had discussed their UI symptoms with a health professional (or parents) and who had sought treatment. Barriers to discussion of UI with health professionals are also noted Study patients with CF to patients with other respiratory conditions as well as healthy controls. 17 No significant difference in the prevalence of UI in both men and women was found between the groups with CF (21%), other respiratory conditions (22%) and healthy controls (17%). Furthermore, in the CF group, UI was not associated with differences in FEV 1 , FVC or BMI.
Studies of men and boys
UI in males with CF has been infrequently studied. In adult men, the prevalence of UI ranges from 5% to 15%. 10, 20, 21 Only one study focused exclusively on men with CF. 20 In this work, 15% of 80 adult men with CF reported occasional UI compared with 10% of 80 healthy controls (P = 0.34). Six percent of men with CF endorsed symptoms of stress UI, which was not reported by healthy control subjects. No association was found between UI and CF disease severity (BMI, FEV 1 , cough frequency, sputum production or dyspnoea).
In two paediatric studies from the UK, Blackwell et al. found that only 2% of 5-18 year old boys with CF experienced UI. Browne et al. reported that 13% of 9-17-year-old boys with CF experienced UI compared with 17% of healthy controls. 15, 17 In the study by Reichman et al., 8% of 25 males and none of the 14 females with CF aged 6-11 years reported UI. 21 
Triggers and associations
All but two studies sought to identify activities that trigger or exacerbate UI in the CF population. The most commonly reported activities were coughing, laughing, sneezing, physical activity, airway clearance and spirometry. [10] [11] [12] [13] [14] [15] [16] [17] 19, 21 In the general population, UI is often associated with constipation or other bowel problems. [22] [23] [24] Less than half of the papers reviewed here explored this association. Most of these found limited evidence linking UI to bowel problems in the CF population. White et al. found that the majority of women surveyed did not experience constipation, diarrhoea or encopresis. 10 Neither the Reichman et al.'s nor the Nixon et al.'s study reported any association of UI with constipation or encopresis. 13, 21 However, two studies found that approximately one-third of patients with UI also experienced faecal incontinence. 14, 15 In a Polish study, females with CF who reported constipation more than occasionally were at higher risk for UI. 19 In community studies, parity is significantly associated with UI. 25, 26 This association has been less well explored in women with CF. Cornacchia et al. identified that 7 of 10 women with CF who had been pregnant reported UI. 11 Orr et al. found that in women who had experienced a pregnancy, half reported that the onset of UI predated childbirth. 12 Only one study explored the association between sexual activity and UI. In the study of Polish young women, decreased UI prevalence was observed in sexually active women (P = 0.04). 19 
Impact
Seven of the 12 published articles explored the effect of UI on airway clearance, exercise and/or spirometry. In these studies, between 16% and 42% of patients reported that UI limited effective airway clearance or chest physiotherapy. [12] [13] [14] 16, 19, 21 Additionally, two studies found that UI affected patients' ability to perform optimal spirometry. 12, 16 Two studies also found that UI negatively impacted patient exercise regimens. 14, 16 In contrast, Blackwell et al. found that none of the 5-18 year olds with UI reported an effect on their chest physiotherapy routine. 15 The majority of studies reported on at least some measure of the impact of UI on patients' lives, with variable findings. Using several measures of patient burden, White et al. reported that respondents experienced minimal impact of UI on their daily activities/plans or their sexual activity. Eighty percent of female respondents with UI reported that UI was 'not a problem' and the remaining 20% reported that it was 'a bit of problem'. 10 Thirty-eight percent of 83 Belgian patients aged 12 years and older with UI reported an adverse effect of UI, primarily on their social life or school/work; few reported limitations in personal life or intimate relationships. 21 In the only study that addressed the impact of UI in males with CF, patients reported they were not significantly bothered by UI. 20 However, reports of depression and anxiety were significantly higher in males with CF and UI compared with males with CF and no UI (P = 0.003 and P = 0.002, respectively).
Conversely, Korzeniewska-Eksterowicz et al. reported that many women felt UI affected their social life, school/work and intimate relationships 'a lot' or 'most of the time' (range: 29-42%). More than half of the sample also reported that UI affected their holidays, social life, school/work and interests/hobbies 'a little bit' or 'a fair bit' (50-58%). 19 A report by Moran et al. also found that half of adult women with UI considered it to be a 'problem' and 14% reported that it impacted on their family and/or social life.
14 Studies of younger patients with CF also varied in their findings of the impact of UI. While in most studies, the majority of participants reported that UI did not have a large effect on their daily life, 13, 15, 17 one study found that 75% of patients felt UI caused significant worry and/or embarrassment. 15 
Discussion of UI with healthcare providers
The ability to determine the clinical impact of how UI affects patients with CF may be limited by underreporting to health professionals and parents. When specifically asked, less than one-third of affected patients with CF reported they had discussed UI with a healthcare provider. [11] [12] [13] [14] [15] [16] [17] [19] [20] [21] In several studies, nearly half of the affected patients had never discussed UI with anyone. 13, 19, 21 While the majority of studies have not explored barriers to discussing UI, embarrassment around UI is commonly reported. 12, 14, 17 Two studies also found that patients may not feel UI is an important issue compared with their CF lung disease.
12,17
Type of UI Several mechanisms may contribute to UI in patients with CF. The principal pathophysiology of UI in CF is felt to be stress incontinence, the involuntary leakage of urine at times of increased intra-abdominal pressure. 22, 25 Additionally, UI is often associated with an overactive bladder or detrusor overactivity, resulting in symptoms of urgency and urge incontinence. 'Giggle' incontinence is an uncommon type of UI in which patients experience voiding during or after laughter in the absence of other features of stress incontinence or of overactive bladder or voiding postponement. 26 Most reviewed studies did not attempt to distinguish the symptoms associated with these types of UI. Of those that did examine UI subtype, most found that symptoms of stress incontinence predominated. 11, 15, 18, 21 Symptoms of stress incontinence were also accompanied by urgency in a subset of affected patients. 15, 21 One study identified a patient with CF experienced giggle incontinence. 15 
Prevention and treatment
There is limited evidence about the prevention and treatment of UI in CF. A minority of affected patients had sought treatment for UI (see Table 1 ). 10, 13, 19, 21 Given mixed findings around the impact of UI on patients with CF, it is unclear if patients with CF do not seek UI treatment because they are not bothered by symptoms or because they are embarrassed to seek help, which would be made worse if they are unaware of treatment options. Orr et al. found that while only 20% of affected patients had discussed UI with a healthcare provider, 35% were interested in treatment options. 12 Most recently, Reichman et al. found that 73% of patients with UI who were aware of treatment had sought help. However, 44% of patients were unaware of UI treatment options. 21 
DISCUSSION
UI is common in both male and female patients with CF. The majority of the studies incompletely described the characteristics of UI, its association with CF disease severity or its impact on patients. These studies were also characterized by inconsistent definitions of UI prevalence and severity and poorly defined classification of patient burden. There were remarkably few studies of men. Despite these limitations, the picture that emerges is significant. UI has the potential to interfere with CF management (e.g. chest physiotherapy, exercise and spirometry), cause personal embarrassment and worry and inhibit recreational, social and intimate activities. At least in one study, three-quarters of patients with UI who were aware of treatment had sought help. 21 Both lack of awareness of UI treatment options and embarrassment around UI function as barriers to care seeking. This suggests that provider-initiated assessment is required to identify UI, consider possible triggers and explore management options. Within the wider CF literature, we failed to identify evidence of routine assessment of UI or standardization of approaches to identifying UI between CF centres. While there are some educational resources, including websites, which target UI or include information about UI within a wider suite of SRH information, there was no evidence that such resources were consistently provided to patients. [27] [28] [29] [30] A recent abstract detailed the successful introduction of a booklet about UI as an educational resource to affected adult women with CF. 31 As many paediatric and adult CF patients view their CF provider as a de facto primary care provider, 9,32 CF providers should be comfortable discussing UI especially given the potential association with disease severity and interference with preventive respiratory interventions such as physiotherapy and exercise. Unclear 'ownership' of UI within CF multidisciplinary teams is likely to contribute to suboptimal care for patients, as has been recently described around other aspects of SRH in CF. 7 Standardization of UI discussions and incorporation within a wider framework of both physiotherapy and SRH education and healthcare would help ensure that patients and families are knowledgeable regarding UI, and that it is routinely assessed. Communication and coordination among the CF team (including CF clinicians and physiotherapists), primary care providers and subspecialists (e.g. adolescent medicine, urology and obstetrics and gynaecology) may be required, especially for more complex cases.
Once UI is identified, a major barrier to care is the lack of a clear management algorithm for patients with CF. Given the potential interplay between bowel and bladder dysfunction, it is reasonable to optimize the bowel regimen of patients with CF with UI. Additionally, as undiagnosed or poorly controlled diabetes may contribute to UI through polydipsia and/or polyuria, screening for CF-related diabetes is warranted. Urine analysis and culture is indicated as undiagnosed urinary tract infections may cause UI. Assessment of symptoms of urgency or overactive bladder is key as it may direct therapy to other behavioural modifications.
Currently, evidence is lacking around successful treatment strategies. Stress UI in CF may be due to musculoskeletal changes leading to abnormal posture, pelvic floor dysfunction and/or poorly regulated intraabdominal pressures. 33 In normal physiological states, the diaphragm and the pelvic floor muscles act in concert in a piston-like fashion. These muscles work in conjunction with abdominal muscle groups to regulate effective breathing, abdominal pressures, posture and continence. [34] [35] [36] [37] [38] [39] [40] Postural abnormalities secondary to hyperinflation and obstructive lung disease are known complications of CF, 41, 42 and the resulting diaphragmpelvic floor dysfunction can lead to UI. 35 Given the interplay between postural muscles and the pelvic floor, physical therapy to strengthen these muscle groups may be effective in treating stress UI in CF. 43 Two techniques have been described: (i) pelvic floor muscle strengthening exercises (commonly referred to as 'Kegels') and (ii) 'The Knack', a contraction of the pelvic floor muscles prior to an increase in intra-abdominal pressure, such as cough. 44 A single study of 12 women with CF suggests that pelvic floor muscle exercises are effective at reducing leakage in the short term. 45 In order to maintain optimal length-tensions relationships, attention to proper alignment of the thoraco-lumbar spine, ribs and pelvis is necessary to optimize the efficacy of this technique. 35 While targeting pelvic floor muscles makes sense physiologically, evaluation of the longer term benefits of such approaches is lacking. Improving the strength of the pelvic floor without simultaneously strengthening other core muscle groups may be less effective.
If the aetiology of UI is unclear and/or conservative management has failed, referral to a urologist or urogynaecologist may be indicated. Vaginal pessaries may be considered as a non-surgical approach to reduce stress UI in women. These are intravaginal support devices controlled by the patient that reduce urine leakage and help pelvic organ prolapse. Incontinence pessaries compress the urethra against the upper posterior portion of the pubic symphysis, causing an increase in urethral resistance that prevents leakage associated with increases in abdominal pressure, such as cough. 46, 47 Patients should be fitted with the pessary and educated around removal and reinsertion by a specialist. Pessary use has not been evaluated in women with CF.
The efficacy of surgical management techniques for stress UI in CF is also unknown. While conservative approaches to management are initially recommended, both vaginal and abdominal surgical approaches can be used for surgical treatment of UI in female patients. Vaginal procedures include midurethral sling, bladder neck sling or injection of urethral bulking agents. 48 Helm et al. successfully utilized tension-free vaginal tape as a repair technique in a small sample of women with CF who did not respond to pelvic floor muscle strengthening. 49 Surgical repair in women should be delayed until child-bearing is complete as pelvic support may be disrupted during pregnancy.
As management of the primary manifestations of CF improves, more attention to extrapulmonary conditions, such as UI, is warranted. Understanding the scope of patients with CF affected by UI and the efficacy of management strategies underpins the provision of comprehensive care for this patient population. Future research, using age-matched controls and a standardized definition of UI inclusive of prevalence, severity and patient burden, is required to further understand the impact of UI in both sexes, as is research that evaluates treatment and preventive interventions.
